CAS 69685-22-9

Butaprost

CAS : 69685-22-9

Butaprost is a prostaglandin analog that inhibits cyclase and polymerase activities. It has been shown to inhibit tumor formation by inhibiting cell proliferation in the skin. Butaprost has a low potency, which means that it takes relatively high doses to be effective. Prostaglandins are lipid compounds that are synthesized from arachidonic acid through the action of cyclooxygenases (COX-1 and COX-2). Prostaglandins have been shown to have anti-inflammatory effects as well as inhibit tumor growth and induce collagen synthesis.

Formule : C₂₄H₄₀O₅

Degré de pureté : Min. 95%

Masse moléculaire : 408.6 g/mol

Ref: 3D-UCA68522

Butaprost

CAS : 69685-22-9

Butaprost: EP2 receptor agonist, EC50=33 nM, Ki=2.4 μM (murine), reduces fibrosis via TGF-β/Smad2.

Formule : C₂₄H₄₀O₅

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 408.57

Ref: TM-T26925